Vétoquinol and Bioniche Life Sciences Inc. Close Sale of Bioniche Animal Health Business
PR Newswire - Tue Apr 15, 8:00PM CDT
Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced the closing of the sale of Bioniche's Animal Health business to Vétoquinol. The two companies announced the signing of a share purchase agreement in February that was subject to the approval of Bioniche shareholders. At a Special Meeting of Shareholders held yesterday, 97.4% of the Shares that were voted were in favour of the transaction.
Bioniche Life Sciences Inc. Shareholders Approve Sale of Animal Health Business
CNW Group - Mon Apr 14, 8:50AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced that its shareholders have voted in favour of the sale of the Company's Animal Health business to Vétoquinol SA.
Bioniche Life Sciences Inc. Continues to Execute on Strategic Review
PR Newswire - Thu Apr 03, 4:00PM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced that it has successfully monetized two non-core properties for net proceeds in excess of $1 million.
ISS Recommends that Bioniche Shareholders Vote in Favour of Animal Health Sale Transaction
PR Newswire - Thu Apr 03, 10:00AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced that Institutional Shareholder Services (ISS) has recommended that shareholders vote FOR the special resolution pertaining to the sale of all of the Corporation's Animal Health business to Vétoquinol SA, to be considered at the upcoming Special Meeting of Shareholders:
Bioniche Life Sciences Inc. Holds Shareholder Conference Call/Webcast
CNW Group - Thu Mar 13, 5:06PM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today held a conference call and audio webcast for its shareholders, at which time, Company representatives provided several corporate updates. The corporate presentation used during today's call/webcast is available on the Company's website (www.Bioniche.com) under Investors - Corporate Presentations.
Bioniche Life Sciences Inc. Announces Key Corporate Updates
CNW Group - Tue Mar 04, 8:00AM CST
Bioniche Life Sciences Inc. (TSX: BNC) announced today key corporate updates:
Vétoquinol to Acquire the Animal Health Business of Bioniche Life Sciences Inc.
PR Newswire - Thu Feb 27, 3:58PM CST
Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million. This agreement remains subject to the approval by shareholders of Bioniche Life Sciences Inc., and the usual closing conditions for a transaction of this type. The Boards of Directors of both corporations have approved the binding agreement, and notice of a special Bioniche shareholder meeting will be forthcoming.
IIROC Trade Resumption - BNC
CNW Group - Thu Feb 06, 12:02PM CST
Trading resumes in:
Bioniche Life Sciences Inc. Reports Fiscal 2014 Second Quarter Results and Announces Strategic Expenditure Review and New One Health Strategy
CNW Group - Thu Feb 06, 11:47AM CST
(all figures are in Canadian dollars unless otherwise noted)
IIROC Trading Halt - BNC
CNW Group - Thu Feb 06, 11:14AM CST
The following issues have been halted by IIROC:
Bioniche Life Sciences Inc. Appoints a Chief Operating Officer
CNW Group - Tue Jan 07, 4:00PM CST
Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a leading clinical stage biotechnology company, today announced the appointment of Donald Olds as Chief Operating Officer, effective immediately.